No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
B.Riley Financial Maintains Harrow(HROW.US) With Buy Rating, Cuts Target Price to $69
Express News | Harrow Inc : B. Riley Cuts Target Price to $69 From $73
10 Health Care Stocks With Whale Alerts In Today's Session
Harrow Says ImprimisRx Unit Wins Jury Verdict in Trademark Infringement Case
Express News | Harrow’s Imprimisrx Subsidiary Receives $34.9 Million Unanimous Jury Verdict Award in Imprimisrx, LLC V. Osrx, Inc.
Express News | Harrow Inc - Melt-300 Shows Statistical Superiority Over Midazolam and Placebo